The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine
- PMID: 3790403
- PMCID: PMC1401174
- DOI: 10.1111/j.1365-2125.1986.tb02936.x
The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine
Abstract
The pharmacokinetics of a novel 20 mg biphasic release tablet of nifedipine were compared with the conventional 10 mg capsule and 20 mg sustained release preparations in healthy volunteers. The influence of food and posture on the pharmacokinetics of the biphasic tablet were studied. In the fasting state, the time to peak concentration of nifedipine was not significantly different between the 20 mg biphasic and 20 mg sustained release tablets, but plasma concentrations were higher between 2 and 4 h after the biphasic tablet. The terminal elimination half-lives of the two formulations were similar. In subjects who fed prior to nifedipine administration there was no significant difference between either the peak plasma concentration or terminal half-life of the biphasic tablet and two 10 mg capsules of nifedipine. When the biphasic preparation was given after a standard breakfast, the time to peak plasma concentration was significantly longer and the terminal half-life shorter than when given in the fasting state. The dissolution characteristics of the biphasic tablet were influenced by prior administration of food to an extent which may be of clinical significance during twice daily administration.
Similar articles
-
Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.Arzneimittelforschung. 1986 Feb;36(2):256-60. Arzneimittelforschung. 1986. PMID: 3964332 Clinical Trial.
-
[Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].Arzneimittelforschung. 1985;35(12):1840-2. Arzneimittelforschung. 1985. PMID: 4096741 Clinical Trial. German.
-
Pharmacokinetics of nifedipine derived from a new retard tablet formulation.Eur J Drug Metab Pharmacokinet. 1990 Oct-Dec;15(4):273-8. doi: 10.1007/BF03190215. Eur J Drug Metab Pharmacokinet. 1990. PMID: 2088764
-
Nifedipine. Relationship between pharmacokinetics and pharmacodynamics.Clin Pharmacokinet. 1987 Jan;12(1):12-29. doi: 10.2165/00003088-198712010-00002. Clin Pharmacokinet. 1987. PMID: 3545614 Review.
-
Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.Clin Pharmacokinet. 1998 Sep;35(3):173-90. doi: 10.2165/00003088-199835030-00002. Clin Pharmacokinet. 1998. PMID: 9784932 Review.
Cited by
-
Slow release nifedipine plus atenolol in chronic stable angina pectoris.Br J Clin Pharmacol. 1989 Nov;28(5):509-16. doi: 10.1111/j.1365-2125.1989.tb03536.x. Br J Clin Pharmacol. 1989. PMID: 2511911 Free PMC article. Clinical Trial.
-
Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.Drugs. 1991 May;41(5):737-79. doi: 10.2165/00003495-199141050-00006. Drugs. 1991. PMID: 1712708 Review.
-
The influence of nutrition on the systemic availability of drugs. Part I: Drug absorption.Klin Wochenschr. 1987 Oct 1;65(19):927-35. doi: 10.1007/BF01745506. Klin Wochenschr. 1987. PMID: 3323642 Review. No abstract available.
-
The influence of posture on the pharmacokinetics of orally administered nifedipine.Br J Clin Pharmacol. 1992 Oct;34(4):332-6. doi: 10.1111/j.1365-2125.1992.tb05639.x. Br J Clin Pharmacol. 1992. PMID: 1457267 Free PMC article. Clinical Trial.
-
Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.Clin Pharmacokinet. 1991 Jan;20(1):1-14. doi: 10.2165/00003088-199120010-00001. Clin Pharmacokinet. 1991. PMID: 2029799 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical